Compounded "semaglutide" is not FDA approved semaglutide.com When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization FDA's Overreach on Compounded Peptides FDA mulls compounding for peptides previously flagged over safety risks BioSpace